Older men who receive pneumococcal vaccine not less likely to have heart attack, stroke: JAMA

NewsGuard 100/100 Score

Men 45 years or older who received pneumococcal vaccine were not less likely to have a heart attack or stroke compared to men who did not receive the vaccine, according to a study in the May 5 issue of JAMA.

Hung Fu Tseng, Ph.D., of Kaiser Permanente Southern California, Pasadena, and colleagues conducted a study to examine the association between vaccination with pneumococcal vaccine and the risk of developing acute heart attack and stroke in men, taking into account known and potentially important confounders (factors that can influence a study, leading to unexpected outcomes that improperly skew the results). The study included Kaiser Permanente Northern and Southern California health plans, with 84,170 participants ages 45 to 69 years from the California Men's Health Study, who were recruited between January 2002 and December 2003, and followed up until December 31, 2007. The cohort was similar to the population of health plan members and men who responded to a general health survey in California on important demographic and clinical characteristics. Demographic and detailed lifestyle characteristics were collected from surveys. Vaccination records were obtained from the Kaiser Immunization Tracking System.

During follow-up, there were 1,211 first myocardial infarctions (MIs; heart attack) in vaccinated persons (rate of 10.7 per 1000 person-years) compared with 1,494 first MI events in unvaccinated individuals (6.07 per 1000 person-years). For stroke, there were 651 events in vaccinated persons (5.3 per 1000 person-years) compared with 483 events in unvaccinated persons (1.9 per 1000 person-years). After analysis of the data, the researchers found no evidence for an association between pneumococcal vaccination and reduced risk of acute MI or stroke. "In addition, association was not observed either in the current smokers, men with history of diabetes, men with history of hypertension, or men of the low-risk group."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Annual COVID-19 vaccine proves to be a wise investment for personal health and pocketbook